Mike deMilt advises life science clients on evolving market dynamics and impactful strategies to guide pipeline optimization, market access, and commercial success.
Prior to joining Avalere, Mike was a vice president at Destum Partners, a boutique biopharma and life science consulting and transaction advisory firm. During his 12 years with the firm, Mike led strategic engagements (market and financial analytics) and supported advisory mandates (buy-side and sell-side transactions) for US, EU, and global clients. With experience leading projects spanning all phases of development across multiple therapeutic areas, Mike provided strategic insight to shape and inform clients' corporate objectives. Prior to that, Mike was a product specialist with the biotechnology company Tetracore, where he supported the development of innovative assets for the detection of infectious diseases and bio-terrorism threat agents.
Mike has a Master's in Biotechnology Enterprise and Entrepreneurship from the Johns Hopkins University and a BS in biology from Radford University.